Endoscopic duodenal therapy shows promise for early Type 2 DM treatment
A study is evaluating the efficacy and safety of endoscopic duodenal re-cellularization therapy for early treatment of Type 2 DM.
Asset / Drug
Drug and asset intelligence for Endoscopic with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.